The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of followup

Journal of Urology

Volumn 155, Issue 4, 1996, Pages 1233-1238

  Tolley, D A ^a   Parmar, M K B ^a   Grigor, K M ^a   Lallemand, G ^a   Beynon, L L ^a   Fellows, S J ^a   Freedman, L S ^a   Hall, R R ^a   Hargreave, T B ^a   Munson, K ^a   Newling, D W W ^a   Richards, B ^a   Robinson, M R G ^a   Rose, M B ^a   Smith, P H ^a   Williams, J L ^a   Whelan, P ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

bladder neoplasms; drug therapy; mitomycin C; randomized controlled trials

Indexed keywords

MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 9044253710     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66226-8     Document Type: Article

References (15)

1. International Union Against Cancer: TNM Atlas - Illustrated Guide to the TNm/pTNm Classification of Malignant Tumours 3rd ed. New York: Springer Verlag, 1992.
2. England, H. R., Blandy, J. P. and Paris, A. M. I.: The treatment of single and multiple papillary tumours of the bladder. In: Bladder Tumours and Other Topics in Urological Oncology. Edited by P. Macaluso, P. H. Smith and F. Edsymr. New York: Plenum Press, pp. 364-462, 1980.
3. Lutzeyer, W., Rübben, H. and Dahm, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127: 250, 1982.
4. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer: The effect of intravesical thiotepa on tumour recurrence after endoscopie treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Brit. J. Urol., 73: 632, 1994.
5. Burnand, K. G., Boyd, P. J. R., Mayo, M. E., Shuttleworth, K. E. D. and Lloyd-Davies, R. W.: Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Brit. J. Urol., 48:55, 1976.
6. Page, B. H., Levison, V. B. and Curwen, M. P.: The site of recurrence of non-infiltrating bladder tumours. Brit. J. Urol., 50: 237, 1978.
7. Boyd, P. J. and Burnand, K. G.: Site of bladder-tumour recurrence. Lancet, 2: 1290, 1974.
8. Tolley, D. A., Hargreave, T. B., Smith, P. H., Williams, J. L., Grigor, K. M., Parmar, M. K. B., Freedman, L. S. and Uscinska, B. M.: Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Brit. Med. J., 296: 1759, 1988.
9. Pocock, S. J.: Clinical Trials: A Practical Approach. Chichester, England: John Wiley, 1990.
10. Parmar, M. K. B. and Machin, D.: Survival Analysis: A Practical Approach. Chichester, England: John Wiley, 1995.
11. Freedman, L., Sylvester, R. and Byar, D.: Using permutation tests and bootstrap confidence limits to analyse repeated events data from clinical trials. Controlled Clin. Trials, 10: 129, 1989.
12. Parmar, M. K. B., Freedman, L. S., Hargreave, T. B. and Tolley, D. A.: Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J. Urol., 142: 284, 1989.
13. Hall, R. R., Parmar, M. K., Richards, A. B. and Smith, P. H.: Proposal for changes in cystoscopic followup of patients with bladder cancer and adjuvant intravesical chemotherapy. Brit. Med. J., 308: 257, 1994.
14. Counsell, C. E., Clarke, M. J., Slattery, J. and Sandercock, P. A.: The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? Brit. Med. J., 309: 1677, 1994.
15. Oosterlinck, W., Kurth, K. H., Schröder, F., Bultinck, J., Hammond, B., Sylvester, R. and Members of the European Organization for Research and Treatment of Cancer Genitourinary Group: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J. Urol., 149: 749, 1993.